Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Odysight.ai is a digital health company specializing in remote monitoring solutions for patients with chronic vision-threatening diseases. The company's flagship product, OdySight, is a mobile application that utilizes medical-grade vision tests and gamification to monitor visual acuity and metamorphopsia in patients with conditions such as age-related macular degeneration and diabetic retinopathy. By enabling real-time monitoring between clinical visits, the platform allows for early detection of disease progression and timely intervention by healthcare providers. Odysight.ai aims to improve clinical outcomes and optimize healthcare resources through its validated digital biomarkers and remote patient management tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Odysight.ai.